Automation index

How much of a Tool and die maker’s job can AI already do?

A CAD file and an electrode come earlier. Fitting the die so the run comes out do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

25%

AI can already do 25% of this job.

#249 / 643

Tool and die maker

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Read the die, clearances and the 3D drawing. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Machine, fit and try the tooling. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Mount in the press, shoot and correct. Estimate No public source provides a precise figure. This is our estimate.	18%	22%	+4
EDM, polish and cavity finish. Estimate No public source provides a precise figure. This is our estimate.	16%	32%	+5.1
Die maintenance and changeovers. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Die life and liability for the part. Estimate No public source provides a precise figure. This is our estimate.	16%	14%	+2.2
Total	100%		25%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 643

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low